Kevin Burnett

Kevin Burnett is a life sciences professional with a demonstrated ability to provide strategic and analytical insights that are accretive to both enterprise and asset values. He is expert at the design and implementation of strategic development programs that achieve significant and sustainable market impact by addressing market access and adoption factors early in the development process.

Kevin has more than 27 years of global strategic development experience, including 17 years as core development/global launch team member on three separate blockbuster [$1 billion+] franchises that transformed their respective markets, as well as the corporate [Allergan] approach to strategic market development. Overall, he has participated in the successful market introduction of over 20 life sciences products, spanning multiple therapeutic segments.

Kevin also has significant management experience, including: [a] founding principal of a successful management advisory and strategic communications firm; [b] creating and managing a corporate department with global responsibilities for a Fortune 500 biopharmaceutical company [Allergan]; [c] building and managing integrated, multidisciplinary teams of professionals with multimillion-dollar budgets; and [d] creating strategic operating plans that allow development-stage companies to achieve value creation milestones with lean operating principles and protocols.

A prolific editor, Kevin has substantial editorial experience across a broad range of publications, including CME-accredited journal supplements to the European Journal of Ophthalmology, Survey of Ophthalmology, the European Journal of Neurology and Cutis, as well as numerous peer-reviewed journal manuscripts and specialty publications. He has been as an invited peer reviewer to UK-based Ashley Publications, and is a published author with by-lined articles appearing in periodicals as diverse as Engineering Horizons, Orange Coast Magazine and Wine Spectator.

He has served as a media spokesperson, representing both technology-specific and general corporate interests. In addition, Kevin co-managed the third most successful open-space bond initiative in the history of California politics and co-managed media for the Dalai Lama when he was awarded the Nobel Prize for Peace.

Kevin is presently a Board Member of the School of Physical Sciences Leadership Council at the University of California, Irvine; has been a guest lecturer for the program in Social Ecology at the UCI; and holds a dual degree from the UCI in Political Science and Psychology with an emphasis on models of decision-making and influence.